FDA warns of very rare Guillain-Barré cases tied to Johnson & Johnson COVID-19 vaccine

Editado por Ed Newman
2021-07-13 21:14:30

Pinterest
Telegram
Linkedin
WhatsApp

The U.S. Food and Drug Administration has added a new warning to Johnson & Johnson’s single-dose COVID-19 vaccine.  

Washington, July 13 (RHC)-- The U.S. Food and Drug Administration has added a new warning to Johnson & Johnson’s single-dose COVID-19 vaccine.  

The FDA reports about 100 cases of the rare autoimmune disorder Guillain-Barré among 12.8 million J&J vaccine recipients in the U.S. The cases were mostly in men aged 50 and older, with one death reported. 

The Food and Drug Administration said in a statement the benefits of the vaccine still clearly outweigh the risks.  A recent study by the Cleveland Clinic found over 99.7% of people hospitalized with COVID-19 were unvaccinated. 



Comentários


Deixe um comentário
Todos os campos são requeridos
Não será publicado
captcha challenge
up